リコンビナント
RabMAb

Anti-eIF5A 抗体 [EP526Y] (ab32443)

ab32443 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab32443 は 6 報の論文で使用されています。

  • Van Rechem C  et al. Lysine demethylase KDM4A associates with translation machinery and regulates protein synthesis. Cancer Discov 5:255-63 (2015). Human . PubMed: 25564516
  • Fujimura K  et al. Eukaryotic Translation Initiation Factor 5A (EIF5A) Regulates Pancreatic Cancer Metastasis by Modulating RhoA and Rho-associated Kinase (ROCK) Protein Expression Levels. J Biol Chem 290:29907-19 (2015). PubMed: 26483550
  • Qin X  et al. Inhibition of eIF5A results in aberrant uterine natural killer cell function and embryo loss in mice. Am J Reprod Immunol 71:229-40 (2014). PubMed: 24382123
  • Fujimura K  et al. A hypusine-eIF5A-PEAK1 switch regulates the pathogenesis of pancreatic cancer. Cancer Res 74:6671-81 (2014). PubMed: 25261239
  • Preukschas M  et al. Expression of eukaryotic initiation factor 5A and hypusine forming enzymes in glioblastoma patient samples: implications for new targeted therapies. PLoS One 7:e43468 (2012). IHC . PubMed: 22927971
  • Patel PH  et al. The Drosophila deoxyhypusine hydroxylase homologue nero and its target eIF5A are required for cell growth and the regulation of autophagy. J Cell Biol 185:1181-94 (2009). WB, IHC-FoFr . PubMed: 19546244

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

登録